IE
OGN icon

Israel Englander’s Organon & Co OGN Stock Holding History

Israel Englander’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-199,400
Closed -$1.93M – 6333
2025
Q2 		$1.93M Buy
+199,400
New +$2.06M ﹤0.01% 3912

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Israel Englander's OGN Position: Q2 2026 in Review

Israel Englander reduced its Organon & Co (OGN) stake by 49% in Q2 2026, selling an estimated $39.9M and leaving 3,442,430 shares worth $46.6M. The position accounts for 0.02% of the portfolio, ranked #948.

Israel Englander first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $88M in Q2 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Israel Englander held 3,442,430 shares of Organon & Co worth $46.6M as of Q2 2026.
  • Israel Englander sold 3,339,105 Organon & Co shares in Q2 2026, an estimated $39.9M.
  • Organon & Co made up 0.02% of Israel Englander's portfolio in Q2 2026, its #948 holding.
  • Israel Englander first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Israel Englander's Organon & Co position peaked at $88M in Q2 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.